Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mario Cerdan Trevino
Safety of Intravenous Alteplase Within 4.5 Hours for Patients Awakening With Stroke Symptoms
PLoS ONE
Multidisciplinary
Related publications
Outcome After Stroke Thrombolysis in Patients >80 Years Treated Within 3 Hours vs >3–4.5 Hours
Neurology
Neurology
Treating Ischaemic Stroke With Intravenous tPA Beyond 4.5 Hours Under the Guidance of a MRI DWI/T2WI Mismatch Was Safe and Effective
Stroke and Vascular Neurology
Neurology
Cardiovascular Medicine
Cardiology
Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke Be Extended to 4.5 Hours?
Canadian Journal of Hospital Pharmacy
Pharmacology
Pharmacy
Simultaneous Treatment With Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Protocol for the Perfusion and Angiography Imaging Sub-Study of the Third International Stroke Trial (IST-3) of Alteplase Treatment Within Six-Hours of Acute Ischemic Stroke
International Journal of Stroke
Neurology
Addressing a Real Life Problem: Treatment With Intravenous Thrombolysis and Mechanical Thrombectomy in Acute Stroke Patients With an Extended Time Window Beyond 4.5 Hours Based on Computed Tomography Perfusion Imaging
European Journal of Neurology
Neurology
Efficacy and Safety of Intravenous Thrombolysis in Patients With Unknown Onset Stroke: A Meta-Analysis
Behavioural Neurology
Medicine
Neurology
Physiological Psychology
Neuropsychology
Effect of IV Alteplase on the Ischemic Brain Lesion at 24–48 Hours After Ischemic Stroke
Neurology
Neurology
Safety of Intravenous Thrombolysis for Stroke in a Patient With Multiple Intracranial Neoplasm
Archives of Neuroscience
Psychiatry
Neuroscience
Mental Health
Neurology
